Loading stock data…
OPRX
$4.92-1.43 (-22.48%)
Pre-Market$5.08+0.16 (+3.28%)· Last close May 13
OptimizeRx Corporation operates as a digital healthcare technology company.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
OptimizeRx Corporation in the Healthcare sector is trading at $4.92. Wall Street consensus targets $14.50 (6 analysts), implying a +195.0% move over the next 12 months. The stock is currently near its 52-week low of $4.57, remaining 61.7% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +195.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 28) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$4.92
Potential Downside
32.2%
Whystock Fair Value$3.33
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus6 analysts
Mean target$14.50+195.0%
Range$10.00 – $20.00
Fundamentals
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, wh...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$127.58M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
25.19
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.28
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-7.69%
Volume
Today's trading volume
2.22M
Recent News
OptimizeRx Corp (OPRX) Q1 2026 Earnings Call Highlights: Strong AI Growth Amid Revenue Challenges
OptimizeRx Corp (OPRX) surpasses estimates with robust AI-enabled solutions, while navigating revenue declines and macroeconomic pressures.
OptimizeRx Q1 Earnings Call Highlights
OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life sciences customers and shorter contract commitments tied in part to most-favored-nation pricing dynamics
OptimizeRx Corporation Q1 2026 Earnings Call Summary
Moby summary of OptimizeRx Corporation's Q1 2026 earnings call
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of +1,300.00% and +7.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Expands EHR Advertising Reach With New DSP Integration
OPRX launched a programmatic EHR ad connection for DSPs, expanding point-of-care targeting and access to authenticated inventory.